[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypertension-in-dialysis-patients\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypertension-in-dialysis-patients":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100610770","phase-2-sodium-bicarbonate-in-intra-dialytic-hypertension-in-chronic-hemodialysis-patients-100610770",false,"NCT07231900","Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients","Inclusion Criteria:\n\n* Chronic hemodialysis patient \\> 3 months\n* 3 dialysis per week, KTV\\>1.2\n* capable of informed concent.\n* rise in blood pressure during hemodialysis \\> 10 mm Hg, for at least 50% of dialysis sessions in the month prior to inclusion.\n* Normal volume status, by clinical physician assessment + bioimpedance\n\nExclusion Criteria:\n\n* age under 18,\n* pregnancy\n* unable to sign informed concent\n* planned for kidney transplant in the following 3 month.\n* congestive heart failure (NYHA 3-4)\n* hospitalization for acute MI or CHF in the past 3 months.\n* low compliece to medical therapy\n* regular pre-dialysis tests with bicarbonate \\> 24 in the past 3 months","ALL","18 Years",{"count":18,"type":19},40,"ESTIMATED","INTERVENTIONAL",[22,23],"PHASE2","PHASE3","The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.",[26],"Hypertension in Dialysis Patients",[28],"Intra-dialytic hypertension","NOT_YET_RECRUITING","2025-11-14",{"date":32,"type":33},"2025-11-17","ACTUAL",{"date":35,"type":19},"2025-11-10",{"date":37,"type":19},"2027-12-01",{"name":39,"class":40},"Assaf-Harofeh Medical Center","OTHER_GOV"]